ArticleJournal of multimorbidity and comorbidity
Multimorbidity clusters and their association with secondary bacterial infections and disease severity among hospitalised COVID-19 patients in Victoria, Australia: Insights from population-wide linked data.
Article in Journal of multimorbidity and comorbidity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited evidence exists on how multimorbidity combinations influence the risk of secondary bacterial infections. This study identified multimorbidity clusters among hospitalised COVID-19 patients in Victoria (2020-2023) and examined their association with secondary bacterial infections and admission outcomes, including ICU admission, hospital and ICU length of stay, and mortality. Methods: We used population-wide linked hospital data and applied cluster analysis to ICD-10 coded chronic conditions to identify multimorbidity clusters. Risks of secondary bacterial infection across clusters were compared to patients with one or no chronic conditions. We used multivariate logistic regression, negative binomial regression, Kaplan-Meier curves, and Cox proportional hazards models to analyse associations with secondary bacterial infection and admission outcomes. Results: Among 179,688 COVID-19 hospital admissions, three multimorbidity clusters were identified: neuropsychiatric, cardiometabolic-multisystem, and neoplastic. Compared to no multimorbidity, each cluster was associated with significantly higher odds of secondary bacterial infection: neuropsychiatric (Odds Ratio (OR) 2.74, 95% CI 2.59-2.89), cardiometabolic-multisystem (OR 3.87, 95% CI 3.63-4.13), and neoplastic (OR 1.98, 95% CI 1.84-2.14; all p<0.001). For patients with secondary bacterial infection, cardiometabolic-multisystem multimorbidity had the highest increase in hospital length of stay (Incident Rate Ratio (IRR) 1.94, 95% CI 1.82-2.05) and ICU length of stay (IRR 2.75, 95% CI 2.36-3.20). Mortality was significantly elevated across all clusters and was highest in the cardiometabolic-multisystem group. Conclusions: Multimorbidity was associated with increased risk of secondary bacterial infection and poorer clinical outcomes in hospitalised COVID-19 patients. Integrating multimorbidity profiles into clinical decision-making may enhance antimicrobial stewardship by identifying patients most likely to benefit from antibiotic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.